1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
How to recondition ex vivo initially rejected donor lungs for clinical transplantation: clinical experience from lund university hospital.
(
- Contribution to journal › Article
- 2010
-
Mark
The reversible oral P2Y(12) antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature.
(
- Contribution to journal › Article
- 2009
-
Mark
Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo.
(
- Contribution to journal › Article
- 2008
-
Mark
The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature
(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
First human transplantation of a nonacceptable donor lung after reconditioning ex vivo.
(
- Contribution to journal › Article
- 2004
-
Mark
ADP Receptor P2Y12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels.
(
- Contribution to journal › Article
- 2003
-
Mark
Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium-derived hyperpolarising factor.
(
- Contribution to journal › Article